Microbix Biosystems Stock Current Asset
| MBX Stock | CAD 0.31 0.01 3.13% |
Microbix Biosystems fundamentals help investors to digest information that contributes to Microbix Biosystems' financial success or failures. It also enables traders to predict the movement of Microbix Stock. The fundamental analysis module provides a way to measure Microbix Biosystems' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Microbix Biosystems stock.
At this time, Microbix Biosystems' Other Current Assets are very stable compared to the past year. As of the 30th of November 2024, Total Current Assets is likely to grow to about 26.9 M, while Non Current Assets Total are likely to drop about 9 M. Microbix | Current Asset |
Microbix Biosystems Company Current Asset Analysis
Microbix Biosystems' Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Microbix Current Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Microbix Biosystems is extremely important. It helps to project a fair market value of Microbix Stock properly, considering its historical fundamentals such as Current Asset. Since Microbix Biosystems' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Microbix Biosystems' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Microbix Biosystems' interrelated accounts and indicators.
Click cells to compare fundamentals
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
Microbix Total Assets
Total Assets |
|
In accordance with the recently published financial statements, Microbix Biosystems has a Current Asset of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The current asset for all Canada stocks is 100.0% higher than that of the company.
Microbix Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Microbix Biosystems' direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Microbix Biosystems could also be used in its relative valuation, which is a method of valuing Microbix Biosystems by comparing valuation metrics of similar companies.Microbix Biosystems is currently under evaluation in current asset category among its peers.
Microbix Biosystems Current Valuation Drivers
We derive many important indicators used in calculating different scores of Microbix Biosystems from analyzing Microbix Biosystems' financial statements. These drivers represent accounts that assess Microbix Biosystems' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Microbix Biosystems' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 27.3M | 72.4M | 69.0M | 42.8M | 38.5M | 22.1M | |
| Enterprise Value | 33.3M | 70.1M | 61.4M | 37.8M | 34.0M | 24.1M |
Microbix Fundamentals
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.0382 | ||||
| Profit Margin | 0.22 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 35.24 M | ||||
| Shares Outstanding | 136.7 M | ||||
| Shares Owned By Insiders | 14.18 % | ||||
| Shares Owned By Institutions | 0.43 % | ||||
| Number Of Shares Shorted | 4.8 K | ||||
| Price To Book | 1.49 X | ||||
| Price To Sales | 1.81 X | ||||
| Revenue | 16.51 M | ||||
| Gross Profit | 11.12 M | ||||
| EBITDA | 1.96 M | ||||
| Net Income | (39.48 K) | ||||
| Cash And Equivalents | 402.12 K | ||||
| Total Debt | 6.65 M | ||||
| Debt To Equity | 0.53 % | ||||
| Current Ratio | 1.64 X | ||||
| Book Value Per Share | 0.20 X | ||||
| Cash Flow From Operations | (1.09 M) | ||||
| Short Ratio | 0.03 X | ||||
| Earnings Per Share | 0.04 X | ||||
| Target Price | 0.8 | ||||
| Beta | 0.34 | ||||
| Market Capitalization | 42.38 M | ||||
| Total Asset | 35.65 M | ||||
| Retained Earnings | (36.91 M) | ||||
| Working Capital | 17.95 M | ||||
| Net Asset | 35.65 M |
About Microbix Biosystems Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Microbix Biosystems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Microbix Biosystems using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Microbix Biosystems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Microbix Biosystems
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Microbix Biosystems position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microbix Biosystems will appreciate offsetting losses from the drop in the long position's value.Moving together with Microbix Stock
Moving against Microbix Stock
The ability to find closely correlated positions to Microbix Biosystems could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microbix Biosystems when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microbix Biosystems - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microbix Biosystems to buy it.
The correlation of Microbix Biosystems is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microbix Biosystems moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microbix Biosystems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microbix Biosystems can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Microbix Stock
Microbix Biosystems financial ratios help investors to determine whether Microbix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.